Drug product development bridges the transition from drug substance manufacturing to clinical and commercial application. At Protheragen, our Drug Product Development services provide integrated formulation, analytical, and process development solutions for biologics, biosimilars, and antibody conjugates. Supported by advanced analytical instrumentation and experienced formulation scientists, we help clients establish stable, scalable, and regulatory-ready drug products for IND and BLA submissions.
Overview of Drug Product Development
Drug product development is a critical stage in biologics development, transforming purified drug substances into safe, stable, and effective finished dosage forms suitable for clinical evaluation and commercial distribution. An optimized drug product not only preserves the biological activity and structural integrity of therapeutic proteins but also improves manufacturability, storage stability, delivery performance, and patient convenience.
Because biologics are highly sensitive to environmental conditions, formulation composition, container closure systems, manufacturing processes, and storage conditions can significantly influence product quality throughout its lifecycle. Therefore, successful drug product development requires a comprehensive understanding of formulation science, analytical characterization, process development, and regulatory expectations.
Fig.1 Infographic of the pharmaceutical pipeline and clinical trials timeline. (Domingues C, et al., 2023)
Our Services
Our formulation development platform covers every critical stage of biologics drug product development.
Formulation Development & Optimization
A well-designed formulation is essential for maintaining the stability, efficacy, and manufacturability of biologic drug products. Our formulation development services focus on optimizing formulation composition, buffer systems, excipients, and product concentration to preserve protein integrity throughout manufacturing, storage, transportation, and clinical application.
Our Capabilities
Formulation screening and optimization
Buffer selection and pH optimization
Excipient compatibility evaluation
Protein concentration optimization
Liquid formulation development
Lyophilized formulation development
Prefilled syringe formulation development
High-concentration formulation optimization
Reconstitution optimization for lyophilized products
Drug Product Process Development
Efficient and scalable manufacturing processes are essential for producing high-quality biologic drug products. Our drug product process development services optimize manufacturing workflows for liquid injectable and lyophilized formulations while ensuring process robustness, reproducibility, and successful scale-up from laboratory development to GMP manufacturing.
Our Capabilities
Liquid injectable process development
Prefilled syringe process development
Lyophilization cycle development
Mixing and formulation preparation optimization
Sterile filtration process development
Aseptic fill-finish process optimization
Process parameter optimization
Scale-up feasibility assessment
Manufacturing process verification
Container Closure Compatibility Studies
Selecting the appropriate container closure system is critical for preserving product quality throughout storage, transportation, and clinical use. We evaluate the compatibility between biologic formulations and packaging materials to minimize product degradation, adsorption, extractables, and other risks that may affect product safety or efficacy.
Our Capabilities
Container closure system selection
Glass vial compatibility studies
Prefilled syringe compatibility studies
Cartridge compatibility assessment
Rubber stopper compatibility evaluation
Drug-container interaction studies
Extractables and leachables risk assessment
Container closure integrity support
Packaging material suitability evaluation
Stability & Stress Studies
Comprehensive stability studies provide critical information for formulation optimization, shelf-life determination, storage recommendations, and regulatory submissions. Our stability programs evaluate product quality under both real-time and accelerated conditions while identifying degradation pathways through stress testing.
Our Capabilities
Long-term stability studies
Accelerated stability studies
Thermal stability evaluation
Freeze-thaw stability studies
Light exposure studies
Agitation and transportation simulation
Oxidative stress studies
pH stress studies
Forced degradation studies
Stability-indicating analytical support
Technology Transfer & Manufacturing Support
Successful technology transfer ensures that drug product manufacturing processes can be reliably reproduced across development, clinical manufacturing, and commercial production. Our technical team supports process transfer, manufacturing readiness, and documentation to enable efficient scale-up and GMP implementation.
Our Capabilities
Process transfer strategy development
Manufacturing documentation preparation
Process parameter transfer
Scale-up support
Engineering batch support
GMP manufacturing readiness
Cross-site technology transfer
Technical troubleshooting
Commercial Formulation Optimization
Commercial manufacturing often requires continuous optimization to improve product quality, manufacturing efficiency, and supply reliability. Our commercial formulation optimization services support lifecycle management through formulation refinement, process improvement, and post-approval manufacturing changes while maintaining product comparability and regulatory compliance.
Our Capabilities
Commercial formulation optimization
Process performance improvement
Manufacturing consistency evaluation
Post-approval change support
Product lifecycle management
Comparability assessment
Process robustness enhancement
Continuous process optimization
Regulatory support for commercial changes
Advanced Technology Platform
Protheragen combines formulation science with state-of-the-art analytical technologies to accelerate drug product development and ensure comprehensive product characterization.
Molecular Stability Analysis
NanoTemper Prometheus NT.48
NanoTemper Stunner
For thermal stability analysis, protein unfolding evaluation, aggregation tendency assessment, and formulation screening.
Particle & Aggregation Characterization
Wyatt Dynamic Light Scattering (DLS)
Micro Flow Imaging (MFI)
Used for particle size distribution, aggregation analysis, subvisible particle characterization, and formulation optimization.
Thermal Analysis
Differential Scanning Calorimetry (DSC)
Supports protein conformational stability evaluation and formulation comparison.
Lyophilization Development Platform
Freeze-Drying Microscope Laboratory Lyophilizer
Pilot-scale Freeze Dryer
Supporting:
Freeze-drying cycle development
Cake structure optimization
Primary drying optimization
Secondary drying optimization
Lyophilized product stability
Why Choose Protheragen
Our drug product development platform combines formulation science, analytical characterization, and manufacturing expertise into an integrated development solution.
Our advantages include:
End-to-end biologics drug product development
One-stop formulation development for biologics and ADCs
Integrated analytical characterization and stability evaluation
Advanced analytical instrumentation platform
Specialized lyophilization development capabilities
Regulatory-oriented CMC development
IND- and BLA-ready documentation support
Close collaboration between formulation, analytical, and manufacturing teams
Through strategic collaboration across our formulation, conjugation, analytical, and manufacturing groups, we provide comprehensive development support that accelerates biologics from laboratory research to clinical trials and commercial production.
Featured Case Studies
Explore how our formulation scientists have helped clients overcome complex drug product development challenges, optimize formulation strategies, and accelerate biologics toward clinical and commercial milestones.
Protein Oxidation Mitigation Through Formulation Optimization
A monoclonal antibody formulation developed light-induced discoloration during stability evaluation. Our formulation scientists identified protein oxidation as the root cause and established an optimized formulation through targeted buffer and antioxidant screening.
Reducing Protein Aggregation in a Bispecific Antibody Formulation
A bispecific antibody formulation exhibited elevated aggregate levels during development. Buffer optimization and analytical characterization enabled the identification of an improved formulation, supporting successful IND submission.
At Protheragen, we provide integrated drug product development solutions that combine formulation expertise, advanced analytical characterization, lyophilization process development, and manufacturing support. Whether you are developing a monoclonal antibody, biosimilar, or antibody-drug conjugate, our multidisciplinary team is committed to delivering stable, scalable, and regulatory-ready drug products that support successful IND and BLA submissions. Contact us to discuss your formulation strategy and discover how our integrated development platform can accelerate your biologics program from formulation design to GMP manufacturing.
Reference
Domingues C, et al. "Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies" Pharmaceutics. 2023; 15(10):2431.
Fig.1 Infographic of the pharmaceutical pipeline and clinical trials timeline. (Domingues C, et al., 2023)
